CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
1.090
+0.050 (4.81%)
At close: Apr 25, 2025, 4:00 PM
1.120
+0.030 (2.75%)
After-hours: Apr 25, 2025, 6:54 PM EDT

CNS Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for CNS Pharmaceuticals.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for CNS Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 11100
Buy 00000
Hold 00011
Sell 00000
Strong Sell 00000
Total 11111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Mar 25, 2025
Maxim Group
Maxim Group
Strong Buy
Upgrades
$25
Strong Buy Upgrades $25 +2,193.58% Sep 10, 2024
Brookline Capital
Brookline Capital
Strong Buy
Initiates
$750,000
Strong Buy Initiates $750,000 +68,807,239.45% Feb 2, 2021
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$825,000
Strong Buy Initiates $825,000 +75,687,973.39% Aug 24, 2020
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-42.97
from -38.87
EPS Next Year
-1.64
from -42.97
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
--37.72M
Revenue Growth
--------
EPS
-----38.87-42.97-1.64-1.86
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a 38.8M
Avg n/a n/a 37.7M
Low n/a n/a 36.2M

Revenue Growth

Revenue Growth 202520262027
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -44.24 -1.69 -1.91
Avg -42.97 -1.64 -1.86
Low -41.29 -1.58 -1.78

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.